Wave Life Sciences completes redomiciliation to Delaware; shares trade under WVE on Nasdaq

Wave Life Sciences Ltd.

On Aug 7, 2026, Wave Life Sciences, Inc. (Delaware) became parent of Wave Life Sciences Ltd. (Singapore) via scheme of arrangement; shares exchanged 1:1.
Wave-Delaware common stock begins trading on Nasdaq under symbol WVE on Aug 10, 2026; CUSIP 94352A104; Singapore shares delisted.
Wave-Delaware assumed all equity plans and outstanding awards; pre-funded warrants now exercisable for Wave-Delaware common stock.
Directors and officers of Wave-Singapore became directors and officers of Wave-Delaware; indemnification agreements entered into.

item 1.01 item 3.02 item 3.03 item 5.03 item 5.01 item 5.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.